Literature DB >> 407907

Antigenic substructure of tetanus neurotoxin.

M Matsuda, M Yoneda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407907     DOI: 10.1016/s0006-291x(77)80192-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  16 in total

1.  Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.

Authors:  M Matsuda; M Kamei; N Sugimoto; Y Ma; S Hashizume
Journal:  Eur J Epidemiol       Date:  1992-01       Impact factor: 8.082

2.  Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.

Authors:  A Haque; N Sugimoto; Y Horiguchi; T Okabe; T Miyata; S Iwanaga; M Matsuda
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Isolation, purification, and characterization of fragment B, the NH2-terminal half of the heavy chain of tetanus toxin.

Authors:  M Matsuda; D L Lei; N Sugimoto; K Ozutsumi; T Okabe
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 4.  Tetanus toxin.

Authors:  B Bizzini
Journal:  Microbiol Rev       Date:  1979-06

5.  Antibodies against the light chain of tetanus toxin in human sera.

Authors:  C S Lin; W H Habig; M C Hardegree
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

Review 6.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

7.  A review of the molecular structure of tetanus toxin.

Authors:  J P Robinson; J H Hash
Journal:  Mol Cell Biochem       Date:  1982-10-01       Impact factor: 3.396

8.  Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity.

Authors:  M Kamei; S Hashizume; N Sugimoto; K Ozutsumi; M Matsuda
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

9.  Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).

Authors:  M Matsuda; K Ozutsumi; P Y Du; N Sugimoto
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

10.  Production and characterization of monoclonal antibodies to tetanus toxin.

Authors:  A J Sheppard; D Cussell; M Hughes
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.